Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program

Julie A Patterson; Tyler D Wagner; John M O'Brien; Jonathan D Campbell

doi:10.1001/jamahealthforum.2023.5237

Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program

JAMA Health Forum. 2024 Feb 2;5(2):e235237. doi: 10.1001/jamahealthforum.2023.5237.

Authors

Julie A Patterson¹, Tyler D Wagner¹, John M O'Brien¹, Jonathan D Campbell¹

Affiliation

¹ National Pharmaceutical Council, Washington, DC.

No abstract available

Plain language summary

This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation.

MeSH terms

Contracts
Insurance Coverage
Medicare Part D*
Negotiating
Prescription Drugs*
United States

Substances

Prescription Drugs